Suchergebnisse - (Subject:"Siltuximab")

PubPharm (121)

91

Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma

enthalten in: Blood | 2014

von San-Miguel, J. | Bladé, J. | Shpilberg, O. | +18

ErratumIn: Blood. 2014 Aug 14;124(7):1201

92

A phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2014

von Angevin, E. | Tabernero, J. | Elez, E. | +19

93

Mechanistic pharmacokinetic/target engagement/pharmacodynamic (PK/TE/PD) modeling in deciphering interplay between a monoclonal antibody and its soluble target in cynomolgus monkeys

enthalten in: The AAPS journal | 2014

von Wang, W. | Wang, X. | Doddareddy, R. | +4

94

A novel approach to evaluate the pharmacokinetic biocomparability of a monoclonal antibody derived from two different cell lines using simultaneous crossover design

enthalten in: The AAPS journal | 2014

von Han, C. | McIntosh, T. | Geist, B. | +7

95

Evaluation of the QTc prolongation potential of a monoclonal antibody, siltuximab, in patients with monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or low-volume multiple myeloma

enthalten in: Cancer chemotherapy and pharmacology | 2014

von Thomas, S. | Suvorov, A. | Noens, L. | +10

96

IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9

enthalten in: Endocrine-related cancer | 2013

von Erb, H. | Langlechner, R. | Moser, P. | +9

97

First IL-6-blocking drug nears approval for rare blood disorder

enthalten in: Nature medicine | 2013

von Williams, S.

98

JAK-STAT blockade inhibits tumor initiation and clonogenic recovery of prostate cancer stem-like cells

enthalten in: Cancer research | 2013

von Kroon, P. | Berry, P. | Stower, M. | +9

99

A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2013

von Kurzrock, R. | Voorhees, P. | Casper, C. | +14

100

A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer

enthalten in: Investigational new drugs | 2013

von Hudes, G. | Tagawa, S. | Whang, Y. | +6

[1]
« Vorheriger
3
4
5
6
7
8
9
10
11
12
13
Nächster »
[13]